MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. (MIST) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 15% planned / 85% discretionary
Largest single sale: $308.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Oliveto Joseph | President and CEO | Sell 10b5-1 | 36,500 | $2.26 | $82.5K | 446,244 −7.6% of holding | |
| Oliveto Joseph | President and CEO | Sell | 34,523 | $1.93 | $66.6K | 482,744 −6.7% of holding | |
| Hasija Amit | CFO & EVP of Corp. Development | Sell | 12,245 | $1.93 | $23.6K | 99,848 −10.9% of holding | |
| Bharucha David | Chief Medical Officer | Sell | 12,245 | $1.93 | $23.6K | 113,181 −9.8% of holding | |
| Nelson Jeffrey Edward | Chief Operating Officer | Sell | 12,245 | $1.93 | $23.6K | 49,848 −19.7% of holding | |
| Muller Lorenz | Chief Commercial Officer | Sell | 11,180 | $1.93 | $21.6K | 205,406 −5.2% of holding | |
| Oliveto Joseph | President and CEO | Sell 10b5-1 | 43,000 | $2.25 | $96.8K | 303,721 −12.4% of holding | |
| Oliveto Joseph | President and CEO | Sell 10b5-1 | 500 | $2.25 | $1.1K | 346,721 −0.1% of holding | |
| Oliveto Joseph | President and CEO | Sell | 133,054 | $2.32 | $308.7K | 450,667 −22.8% of holding | |
| Hasija Amit | CFO & EVP of Corp. Development | Sell | 58,007 | $2.32 | $134.6K | 91,993 −38.7% of holding | |
| Bharucha David | Chief Medical Officer | Sell | 58,007 | $2.32 | $134.6K | 105,326 −35.5% of holding | |
| Nelson Jeffrey Edward | Chief Operating Officer | Sell | 58,007 | $2.32 | $134.6K | 41,993 −58% of holding | |
| Muller Lorenz | Chief Commercial Officer | Sell | 53,566 | $2.32 | $124.3K | 196,486 −21.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.